Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Juan C. Almagro(Pfizer (United States)), Manuel L. Penichet(University of California, Los Angeles)
Cited by 159
Related Papers
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
|Nature Communications|2019|297
Levels of Murine, but Not Human, CXCL13 Are Greatly Elevated in NOD-SCID Mice Bearing the AIDS-Associated Burkitt Lymphoma Cell Line, 2F7
|PLoS ONE|2013|14
Antibody Engineering and Therapeutics
|mAbs|2014|6